Advertisement

Opioids

FDA Approves Ubrelvy for Acute Migraine Treatment

Significantly more patients treated with Ubrelvy versus placebo achieved pain freedom two hours post-treatment TUESDAY, Dec. 24, 2019 (HealthDay News) — Ubrelvy (ubrogepant) tablets have been approved for acute treatment...

Number of Children With Opioid Poisonings Increasing

Percentage of critical care admissions and suicidal intent increased in each era. MONDAY, Dec. 30, 2019 (HealthDay News) — The severity of pediatric admissions for acute opioid ingestions, especially following attempted...

Overdose, Relapse After Buprenorphine Discontinuation High

The longer patients continue with buprenorphine treatment, the lower their risk of adverse outcomes.   THURSDAY, Dec. 26, 2019 (HealthDay News) — Buprenorphine treatment may be needed for several years after an opioid...

Loading